XRF Scientific Gelecekteki Büyüme

Future kriter kontrolleri 2/6

XRF Scientific kazanç ve gelirin sırasıyla yıllık 11.8% ve 8.8% oranında artacağı tahmin edilmektedir. EPS'nin yıllık 11.4% oranında büyümesi beklenmektedir. Özkaynak kârlılığının 3 yıl içinde 17.8% olacağı tahmin edilmektedir.

Anahtar bilgiler

11.8%

Kazanç büyüme oranı

11.4%

EPS büyüme oranı

Machinery kazanç büyümesi	33.2%
Gelir büyüme oranı	8.8%
Gelecekteki özkaynak getirisi	17.8%
Analist kapsamı	Low
Son güncelleme	15 Oct 2024

Gelecekteki son büyüme güncellemeleri

Analysts Have Made A Financial Statement On XRF Scientific Limited's (ASX:XRF) Annual Report

Aug 21

Recent updates

Analysts Have Made A Financial Statement On XRF Scientific Limited's (ASX:XRF) Annual Report

Aug 21

Why The 22% Return On Capital At XRF Scientific (ASX:XRF) Should Have Your Attention

Oct 05

XRF Scientific (ASX:XRF) Is Increasing Its Dividend To A$0.033

Sep 19

XRF Scientific's (ASX:XRF) Upcoming Dividend Will Be Larger Than Last Year's

Aug 28

Do XRF Scientific's (ASX:XRF) Earnings Warrant Your Attention?

Aug 22

Does XRF Scientific (ASX:XRF) Deserve A Spot On Your Watchlist?

Feb 01

XRF Scientific (ASX:XRF) Seems To Use Debt Rather Sparingly

Oct 19

We Think XRF Scientific (ASX:XRF) Can Manage Its Debt With Ease

May 12

XRF Scientific (ASX:XRF) Shareholders Will Want The ROCE Trajectory To Continue

Apr 21

Is Now The Time To Put XRF Scientific (ASX:XRF) On Your Watchlist?

Oct 01

XRF Scientific (ASX:XRF) Is Looking To Continue Growing Its Returns On Capital

May 18

Does XRF Scientific (ASX:XRF) Have A Healthy Balance Sheet?

Apr 19

An Intrinsic Calculation For XRF Scientific Limited (ASX:XRF) Suggests It's 23% Undervalued

Mar 17

XRF Scientific (ASX:XRF) Strong Profits May Be Masking Some Underlying Issues

Mar 01

Is Now The Time To Put XRF Scientific (ASX:XRF) On Your Watchlist?

Feb 17

Our View On XRF Scientific's (ASX:XRF) CEO Pay

Jan 27

Who Has Been Selling XRF Scientific Limited (ASX:XRF) Shares?

Jan 12

XRF Scientific Limited's (ASX:XRF) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

Dec 23

XRF Scientific Limited's (ASX:XRF) Intrinsic Value Is Potentially 22% Below Its Share Price

Dec 10

The Returns At XRF Scientific (ASX:XRF) Provide Us With Signs Of What's To Come

Nov 25

Kazanç ve Gelir Büyüme Tahminleri

ASX:XRF - Analistlerin gelecek tahminleri ve geçmiş finansal verileri (AUD Millions )
Tarih	Gelir	Kazançlar	Serbest Nakit Akışı	Faaliyetlerden Nakit	Avg. Analist Sayısı
6/30/2027	78	13	12	13	1
6/30/2026	70	11	10	12	1
6/30/2025	63	10	8	11	1
6/30/2024	60	9	6	8	N/A
3/31/2024	58	9	7	8	N/A
12/31/2023	57	8	7	8	N/A
9/30/2023	56	8	7	8	N/A
6/30/2023	55	8	8	8	N/A
3/31/2023	52	7	5	6	N/A
12/31/2022	49	7	3	4	N/A
9/30/2022	44	7	3	3	N/A
6/30/2022	40	6	3	3	N/A
3/31/2022	37	6	3	4	N/A
12/31/2021	35	6	4	5	N/A
9/30/2021	33	5	4	5	N/A
6/30/2021	31	5	4	5	N/A
3/31/2021	30	5	4	5	N/A
12/31/2020	28	4	5	5	N/A
9/30/2020	29	3	4	5	N/A
6/30/2020	29	3	3	4	N/A
3/31/2020	29	3	3	4	N/A
12/31/2019	30	3	2	3	N/A
9/30/2019	29	2	3	3	N/A
6/30/2019	29	2	3	4	N/A
3/31/2019	28	2	2	2	N/A
12/31/2018	27	2	0	1	N/A
9/30/2018	26	1	0	1	N/A
6/30/2018	24	1	-1	1	N/A
3/31/2018	24	1	N/A	1	N/A
12/31/2017	23	1	N/A	1	N/A
9/30/2017	22	1	N/A	0	N/A
6/30/2017	22	1	N/A	0	N/A
3/31/2017	22	1	N/A	1	N/A
12/31/2016	22	1	N/A	1	N/A
9/30/2016	21	1	N/A	1	N/A
6/30/2016	21	2	N/A	0	N/A
3/31/2016	20	2	N/A	1	N/A
12/31/2015	20	2	N/A	2	N/A
9/30/2015	20	2	N/A	3	N/A
6/30/2015	21	3	N/A	4	N/A
3/31/2015	21	3	N/A	4	N/A
12/31/2014	22	3	N/A	3	N/A
9/30/2014	22	3	N/A	3	N/A
6/30/2014	22	2	N/A	3	N/A
3/31/2014	21	3	N/A	3	N/A
12/31/2013	20	3	N/A	3	N/A

Analist Gelecek Büyüme Tahminleri

Kazançlar ve Tasarruf Oranları: XRF 'nin tahmini kazanç büyümesi (yıllık 11.8% ) tasarruf oranının ( 2.4% ) üzerindedir.

Kazançlar ve Piyasa: XRF şirketinin kazançlarının (yıllık 11.8% ) Australian pazarından (yıllık 12.3% ) daha yavaş büyümesi öngörülüyor.

Yüksek Büyüme Kazançları: XRF şirketinin kazançlarının artması bekleniyor, ancak önemli ölçüde.

Gelir ve Pazar: XRF şirketinin gelirinin (yıllık 8.8% ) Australian pazarından (yıllık 5.6% ) daha hızlı büyümesi öngörülüyor.

Yüksek Büyüme Geliri: XRF şirketinin gelirinin (yıllık 8.8% ) yıllık 20% oranından daha yavaş büyümesi öngörülüyor.

Hisse Başına Kazanç Büyüme Tahminleri

Gelecekteki Özkaynak Getirisi

Gelecekteki ROE: XRF 'nin Özsermaye Getirisi'nin 3 yıl içinde düşük olması tahmin ediliyor ( 17.8 %).

XRF Scientific Gelecekteki Büyüme

Future kriter kontrolleri 2/6

Anahtar bilgiler

Gelecekteki son büyüme güncellemeleri

Price target increased by 8.0% to AU$1.75

Analysts Have Made A Financial Statement On XRF Scientific Limited's (ASX:XRF) Annual Report

Price target increased by 19% to AU$1.55

Price target increased to AU$0.65

Price target increased to AU$0.46

Recent updates

Price target increased by 8.0% to AU$1.75

XRF Scientific Limited, Annual General Meeting, Oct 21, 2024

Upcoming dividend of AU$0.039 per share

XRF Scientific Limited Announces Ordinary Full Franked Dividend for the Twelve Months Ended June 30, 2024, Payment Date of September 27, 2024

Analysts Have Made A Financial Statement On XRF Scientific Limited's (ASX:XRF) Annual Report

Full year 2024 earnings: EPS and revenues exceed analyst expectations

XRF Scientific Limited (ASX:XRF) completed the acquisition of remaining 50% stake in Orbis Mining Pty. Ltd. for AUD 3.8 million.

Now 22% undervalued

Price target increased by 19% to AU$1.55

XRF Scientific Limited to Report Fiscal Year 2024 Results on Aug 20, 2024

Now 24% undervalued

Now 24% undervalued

Now 24% undervalued

Now 24% undervalued

Now 24% undervalued

Now 25% undervalued

Now 23% undervalued

Now 23% undervalued

Now 22% undervalued

Now 20% undervalued

XRF Scientific (ASX:XRF) Seems To Use Debt Rather Sparingly

Now 21% undervalued

First half 2024 earnings released: EPS: AU$0.033 (vs AU$0.028 in 1H 2023)

Is Now The Time To Look At Buying XRF Scientific Limited (ASX:XRF)?

Returns On Capital Are A Standout For XRF Scientific (ASX:XRF)

New minor risk - Market cap size

Investor sentiment improves as stock rises 15%

Now 22% undervalued after recent price drop

Why The 22% Return On Capital At XRF Scientific (ASX:XRF) Should Have Your Attention

XRF Scientific Limited, Annual General Meeting, Oct 31, 2023

Upcoming dividend of AU$0.033 per share at 3.0% yield

XRF Scientific (ASX:XRF) Is Increasing Its Dividend To A$0.033

XRF Scientific's (ASX:XRF) Upcoming Dividend Will Be Larger Than Last Year's

New minor risk - Dividend sustainability

Full year 2023 earnings: EPS and revenues miss analyst expectations

Do XRF Scientific's (ASX:XRF) Earnings Warrant Your Attention?

XRF Scientific Limited Announces Ordinary Fully Paid Dividend for the Twelve Months Ended June 30, 2023, Payment Date of October 13, 2023

Non-Executive Director recently bought AU$89k worth of stock

New minor risk - Market cap size

Investor sentiment improves as stock rises 19%

Non-Executive Director recently bought AU$61k worth of stock

Investor sentiment improves as stock rises 18%

Now 23% undervalued

First half 2023 earnings released: EPS: AU$0.028 (vs AU$0.021 in 1H 2022)

Does XRF Scientific (ASX:XRF) Deserve A Spot On Your Watchlist?

Insufficient new directors

Now 21% undervalued

XRF Scientific (ASX:XRF) Seems To Use Debt Rather Sparingly

XRF Scientific Limited Announces Dividend That Relates to the Financial Reporting or Payment Period Ended on June 30, 2022, Payable on October 14, 2022

Upcoming dividend of AU$0.025 per share

XRF Scientific Limited, Annual General Meeting, Oct 21, 2022

Full year 2022 earnings released: EPS: AU$0.045 (vs AU$0.038 in FY 2021)

XRF Scientific Limited Announces Fully Franked Ordinary Dividend for the Year Ended June 30, 2022, Payable on 14 October 2022

Now 20% undervalued

We Think XRF Scientific (ASX:XRF) Can Manage Its Debt With Ease

Now 24% undervalued

Price target increased to AU$0.65

Insufficient new directors

XRF Scientific (ASX:XRF) Shareholders Will Want The ROCE Trajectory To Continue

First half 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Insufficient new directors

Is Now The Time To Put XRF Scientific (ASX:XRF) On Your Watchlist?

Upcoming dividend of AU$0.02 per share

Full year 2021 earnings released: EPS AU$0.038 (vs AU$0.023 in FY 2020)

Price target increased to AU$0.46

Non-Executive Director recently bought AU$72k worth of stock

XRF Scientific (ASX:XRF) Is Looking To Continue Growing Its Returns On Capital

Does XRF Scientific (ASX:XRF) Have A Healthy Balance Sheet?

An Intrinsic Calculation For XRF Scientific Limited (ASX:XRF) Suggests It's 23% Undervalued

XRF Scientific (ASX:XRF) Strong Profits May Be Masking Some Underlying Issues